- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
P15-23. Community engagement strategies in the Canadian HIV vaccine initiative ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Creator
-
Milsom, P.
- Contributor
-
Cryan, C.
Sternthal, S.
Harmston, C.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P224
- URN
-
urn:nbn:de:1111-2016080710036
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Milsom, P.
- Cryan, C.
- Sternthal, S.
- Harmston, C.
- SpringerLink (Online service)
Other Objects (12)
P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey
HIV prevention by vaccine
Prospecting for an HIV vaccine
HIV vaccine research in Canada
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Is an HIV vaccine achievable? - Pros
P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Toward a glycopeptide-based HIV-1 vaccine
mRNA-based vaccine technology for HIV
P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey
HIV prevention by vaccine
Prospecting for an HIV vaccine
HIV vaccine research in Canada
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Is an HIV vaccine achievable? - Pros
P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Toward a glycopeptide-based HIV-1 vaccine
mRNA-based vaccine technology for HIV
P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey
HIV prevention by vaccine
Prospecting for an HIV vaccine
HIV vaccine research in Canada
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Is an HIV vaccine achievable? - Pros
P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Toward a glycopeptide-based HIV-1 vaccine